â??Effect of behavioural counseling, Behavioural counseling and Bupropion and Behavioural Counseling, Bupropion and Nicotine chewing Gums in tobacoo cessation.

â??Efficacy of different models of tobacco cessation intervention- A Randomised Controlled Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/11/006346

Enrollment

150

Registered

2015-11-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nicotine Replacement Therapy and Bupropion: NRT FROM Cipla Bupropion from sunpharma NRT and Bupropion will be given weekly for 3 months followed by follow up once in 4,5 and 6 month. C

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-50 years. 2. Persons who described themselves as current smokers and smoke more than 6 bidis or cigarettes /day. 3. Motivated to quit smoking. . 4. According to The Stages of Readiness to change model subjects in the Action Stage will be selected for study. 5. According to Fagerstrom Tolerance Questionnaire subjects with score of 6 or more which indicate moderate to high dependence will be selected. 6. Only one member from a family will be included in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1. Serious or unstable cardiac, renal, hypertensive, pulmonary, endocrine or neurologic disorders 2. A current diagnosis of major depressive episode or a history of panic disorder. 3. Psychosis, bipolar disorder, eating disorder, use of nicotine replacement therapy within six months before study enrollment. 4. Pregnancy, lactation. 5. Abuse of alcohol or a non nicotine containing drug within the preceding year. 6. Prior use of Bupropion. 7. Current use of NRT with smoking. 8. Regular use of any non cigarette tobacco product. 9. Family history of seizures. 10. History of severe head trauma. 11. Allergy to any of the medication. 12. Subjects already enrolled in any other intervention programs. 13. Those who cannot read or write. (cannot maintain diaries) 14. Those with MPDS and other chewing difficulties.

Design outcomes

Primary

Measure	Time frame
Days of Abstinence from smokingTimepoint: 6 months	—

Secondary

Measure	Time frame
Fagerstorm scale for nicotine dependenceTimepoint: 6 Months	—

Countries

India

Contacts

Public ContactDr Ankita Piplani

Postgraduate Institute of Dental Sciences, Rohtak

adarshkumar1980@gmail.com9468110075

Outcome results